7/8/11 Contest Update
Investors with a biblical bent might think of it as a Job rather than jobs report. And, undoubtedly, the hellish employment numbers set the Satanic shorts gloating. Still, despite Friday’s news, stocks managed a gain for the week.
At Friday’s close, the Nasdaq Biotech Index was up 17.49% YTD (vs. up 15.50% YTD a week ago) and the Contest median was up 18.70% YTD (vs. up 15.39% YTD a week ago). The Nasdaq Composite Index was up 7.80% YTD (vs. up 6.15% YTD a week ago).
GENE’s portfolio (up 64.04% YTD) held on to first place. But both second place MCBIO’s portfolio (up 56.76% YTD) and third place ROCKY’s portfolio (up 54.74% YTD) had excellent weeks, significantly narrowing GENE’s lead.
At Friday's close, 33 of the 38 Contest portfolios were in the black, while 21 of the 38 were beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: ROSG does 1-4 reverse split
Have a terrific weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
7/8/11
Rank Name Profit/Loss
1 GENE 64,037
2 MCBIO 56,763
3 ROCKY 54,741
4 FIB 54,166
5 CRAZYP 50,911
6 RRGE 50,731
7 JIBAC 43,870
8 IJF 39,341
9 RKRW 38,291
10 GHMM 34,129
Week's Top 5 Gainers
Symbol 7/1 7/8 % change
BPAX 2.91 3.60 23.71%
MRNA 0.19 0.23 23.19%
DCTH 5.20 6.34 21.92%
ZLCS 2.33 2.76 18.45%
FOLD 6.28 7.33 16.72%
Week's Top 5 Losers
Symbol 7/1 7/8 % change
NRGX.OB 0.78 0.65 -16.67%
AFFX 8.06 6.79 -15.76%
IDRA 2.23 1.90 -14.80%
CPHD 35.31 32.40 -8.24%
ONTY 9.30 8.54 -8.17% |
